Abdulla A. Damluji, MD, PhD @DrDamluji Twitter profile

Last Seen Profiles

@Danielledeco

@jessicawalliser

@hinari_egg

@voige

@zyasuoki

@AnthWalker24

@thoulton

@vikassindhwani

@MadamWanderBeki

@therealjeremyjr

@NinjaMack1

@Kilianvasica

@IyawoThickaBody

@KCRoosMSoccer

@ReadingRoyals

@SoccerPulseApp

@HstlandHrtmedia

@GutsoverfearIE

@Kirjakulov

@amateurgourmet

@HochmanGuy

@IsraelCR_

@isaiah_ybarra98

@tiltify

@MyRoosterWisdom

@KRIEGSNOMADE

@BIM_Finance

@Aliceshionotak1

@HarikoChokan

@Caterina_Online

@EsteparioDrums

@Polk_Athletics

@gaysport31

@Megafires1

@CryheartVT

@Runa_cp

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Right Ventricular Failure: @NEJM In-depth review on the right heart: @Brian_Houston12 @RyanTedfordMD Will try to hit the highlights, but cannot substitute for the details in the full text! 👇👇

17

287

1K

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 years

***IVUS Basics*** Tweetorial #cardiotwitter 1/ IVUS Guide Catheter

20

300

813

Abdulla A. Damluji, MD, PhD

@DrDamluji

10 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals * I am reading this slowly: let's summarize in threads Read full document:🥸 Thread #1 👇👇👇

4

222

710

Abdulla A. Damluji, MD, PhD

@DrDamluji

6 months

Great #AHA23 so far: @AHA_Research 🥸8 Trials: 8 take aways below Read the read👇👇 1/ATRESIA: Patients with subclinical atrial fibrillation can benefit from apixaban to reduce the risk of stroke and systemic thromboembolism.

11

201

639

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction A Report of the American College of Cardiology Solution Set Oversight Committee: @JACCJournals Dense document, but will try to break it down w threads Starting here👇👇👇

6

175

589

Abdulla A. Damluji, MD, PhD

@DrDamluji

4 months

Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention: @JACCJournals 🥸 Sorry been away 😱Here are few summary points about STOPDAPT-2 👇👇

7

147

528

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association: @CircAHA AHA Statement from out council: @AHA_AcuteCVCare Here is a summary 👇👇👇

9

172

497

Abdulla A. Damluji, MD, PhD

@DrDamluji

6 months

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes: @NEJM The select trial: #AHA23 🥸Wow! @AHA_Research 😱Now on the stage in main event 😱Let's get the highlights 👇👇👇

5

64

340

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

I saw this in a presentation by a senior statistician: brilliant! #statistics #datascience

6

79

338

Abdulla A. Damluji, MD, PhD

@DrDamluji

10 months

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events: @JACCJournals *** Great - this is what @AHAScience recommended for older higher risk patients: @MichaelGNanna 25-point summary in am report: (they are short sentences 😱) 👇👇👇

12

109

326

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 years

6

34

265

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF: @CircAHA Great topic - important in practice, specifically in terms of renal function. 10-points below: 👇👇👇

1

88

265

Abdulla A. Damluji, MD, PhD

@DrDamluji

9 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals Guidelines are detailed: reading it slowly. Please, read full doc! Thread #10 : Lipid management and chronic coronary disease? 🥸

9

72

264

Abdulla A. Damluji, MD, PhD

@DrDamluji

8 months

Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction: The FIRE Trial @NEJM Outstanding work by @SimoneBiscaglia and colleagues: advancing care for older adults living with ACS 👏🎩 Let's summarize it here: with our 2 friends 🥸😱 👇👇👇

7

64

264

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease A Randomized Clinical Trial: @JAMA_current High intensity statin rate of MACE at 3 years = 8.7% LDL target 50-70 mg/dL = 8.1% Here is 10 point summary 👇👇👇

6

73

252

Abdulla A. Damluji, MD, PhD

@DrDamluji

8 months

Impact of Complete Revascularization in the ISCHEMIA Trial: @JACCJournals How do you interpret the results of this ischemia sub-study? The devil is in the detail. 😱 Good morning: 🥸 Below 👇👇

5

73

259

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Acute Effects of Coffee Consumption on Health among Ambulatory Adults: @NEJM This is fun. Few remarks: small sample (type ii error is a concern), a lot of confounders (still remain) in part related to blinding, mediations, and adherences. Great attempt though! Summary 👇👇

11

63

246

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association: @CircAHA Here are few points to summarize 👇👇

5

118

244

Abdulla A. Damluji, MD, PhD

@DrDamluji

5 months

Critical Care Management of Patients After Cardiac Arrest: A Scientific Statement From the American Heart Association and Neurocritical Care Society: @CircAHA 🥸Great work: @AHA_Research @AHA_AcuteCVCare 😱Let's summarize: Happy Sunday :) 👇👇👇

1

78

214

Abdulla A. Damluji, MD, PhD

@DrDamluji

8 months

Relationship of Daily Step Counts to All-Cause Mortality and Cardiovascular Events: @JACCJournals * So sorry for absent; many deadlines all at once :) 🥸 How Many Daily Steps Are Linked to Reduced Mortality and CVD Risk? 😱😱😱 Let'd do it 👇👇👇

6

61

212

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 years

Mechanical Complications of Acute Myocardial Infarction Published today in @CircAHA I am grateful to the amazing people who I learned so much from: @seanvandiepen @JasonKatzMD @venumenon10 @HollandTamis @DrMauricioCohen Top Things to Know in a Tweetorial below (1/11)

3

71

212

Abdulla A. Damluji, MD, PhD

@DrDamluji

6 months

Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia: @NEJM 🥸and here is the MINT trial: #AHA23 @AHA_Research 😱Summary 👇👇👇

1

47

210

Abdulla A. Damluji, MD, PhD

@DrDamluji

10 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals * I am reading this slowly: on risk assessment of future MACE Read full document:🥸 Thread #2 📷

1

51

201

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Management of Cardiogenic Shock Unrelated to Acute Myocardial Infarction 1/7 The primary goals of cardiogenic shock treatment are to restore and maintain adequate cardiac output, normalize cardiac filling pressures, and normalize total body volume

2

57

188

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Heart Failure With Preserved Ejection Fraction: @JACCJournals Scientific Statement For those of us who write scientific statements, there is a lot to learn from the level of depth in this work! Brilliant 👏👏👏 Where do you start? 👇👇👇

2

46

182

Abdulla A. Damluji, MD, PhD

@DrDamluji

2 years

When compared with the Mediterranean, most of us live in prisons!

13

4

171

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Management of Mechanical Prosthetic Heart Valve Thrombosis: @JACCJournals Review Topic of the Week Fabulous review from the Washington Hospital Center Team...It is dense, but will try to break it down: 👇👇👇

3

60

174

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes A Post Hoc Analysis of the HOST-EXAM Trial: @JAMACardio Here are some data to support Plavix monotherapy over aspirin alone +/- DM Summary 👇👇

3

46

170

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis: @JACCJournals 1/ This is great: Primary prevention in older adults >75 years of age 2/ Moderate intensity + ezetimibe is probably better tolerated Here is 10-point summary

6

59

166

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 years

6

20

162

Abdulla A. Damluji, MD, PhD

@DrDamluji

11 months

Effects of Elective Coronary Revascularization vs Medical Therapy Alone on Noncardiac Mortality: @JACCJournals Chronic coronary disease management and long term non-cardiac mortality: @ElianoNavarese Here is a brief summary 👇👇

3

55

163

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Thread #5 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: @JACCJournals Management of HFpEF: Continued with MRAs Starting from #38 : 👇👇👇

7

53

159

Abdulla A. Damluji, MD, PhD

@DrDamluji

9 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals Guidelines are detailed: reading them slowly. Please, read full doc! Thread #15 : What is need/duration of beta blockers in coronary disease? 🥸📷👇

4

48

160

Abdulla A. Damluji, MD, PhD

@DrDamluji

2 months

Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial: @CircAHA 🥸Let's summarize - good morning 👇👇👇

4

33

158

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Management of ACS in The Older Adult Populations: @CircAHA I am very grateful to @American_Heart faculty who I learned so much from @DEF_gericard @TYWangMD @JoChikweMD @VijayKunadian @KAlexanderMD Top things to know (credit to @Ben_Kelemen ) 👇👇👇

6

66

158

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Management of Stable Angina in the Older Adult Population: @CircIntv - This time I get to summarize our work led by my friend @MichaelGNanna 20-point summary 🧵 👇👇👇

4

63

159

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Intravascular Imaging–Guided or Angiography-Guided Complex PCI: @NEJM #ACC23 Update Renovate-Complex-PCI Trial 📢 9-Point Summary 📢 👇👇

2

43

158

Abdulla A. Damluji, MD, PhD

@DrDamluji

9 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals * I am reading this slowly; only way to read these thick documents: On goals of treatment and shared decision making! 🥸 Thread #3 👇👇👇

1

41

156

Abdulla A. Damluji, MD, PhD

@DrDamluji

4 years

Today, I received the notice of K23 award from the @nih_nhlbi to study frailty and resilience in older adults with AMI... It took 4.5 years, but here we are. Thought on how to do it are below [if anyone wants to learn from my mistakes - I made plenty of mistakes] 1/12

36

19

156

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 years

8

36

152

Abdulla A. Damluji, MD, PhD

@DrDamluji

11 months

Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease: @JACCJournals My friend @MichaelGNanna is studying the effects of beta blockers and calcium channel blockers in older pts with SIHD: @PCORI 15-point summary 👇👇👇

3

52

147

Abdulla A. Damluji, MD, PhD

@DrDamluji

9 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals Guidelines are detailed: reading it slowly. Please, read full doc! Thread #12 : What does the new guidelines say about SGLT2i/GLP-1 agonists for CCD? 🥸 👇👇

4

45

141

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial: @ESC_Journals 6-point summary 👇👇

3

43

139

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Summary 👇👇👇

3

36

138

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Outcomes of Medical Therapy Plus PCI for Multivessel or Left Main CAD Ineligible for Surgery: @JACCJournals Agree with the results: this is what we see in practice 4-point Summary below... 👇👇👇

4

48

135

Abdulla A. Damluji, MD, PhD

@DrDamluji

4 months

Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk Post Hoc Analysis of the TALOS-AMI Randomized Clinical Trial: @JAMACardio 🥸This is on de-escalation of DAPT in AMI setting. 😱Summary below and happy holidays

3

45

129

Abdulla A. Damluji, MD, PhD

@DrDamluji

9 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals * I am reading this slowly & summarizing: Read full doc Thread #5 *** Do you know what the recent CCD guidelines recommend on nutrition? 😱😱 Read below👇👇

1

32

127

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Sarcopenia and Cardiovascular Diseases: @CircAHA From the Geriatric Cardiology Leadership Council: @ACCinTouch Main congratulations to @Dr_Alfaraidy : a board certified geriatrician and a cardiology fellow - she is amazing AND the best: @ParagGoyalMD 👏 Summary👇👇👇

3

47

128

Abdulla A. Damluji, MD, PhD

@DrDamluji

2 years

Re: ideas on #risk , #prediction , #data , and #life , which were inspired by a #random phone call during a break from classes @NYUStern : Short thread below 👇🏻 @nntaleb

8

28

123

Abdulla A. Damluji, MD, PhD

@DrDamluji

5 months

Hi Everyone, Here is the Summary Results for Key Late-Breaking Science at Scientific Sessions 2023 for #AHA23 @AHAScience @AHA_Research (1/3) 👇👇👇

3

37

119

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up: @JACCJournals The promise of drug coated balloons for small vessels (2 to 2.75mm)! Summary 👇👇👇

1

36

121

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Thread #4 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: @JACCJournals Focusing on Management of HFpEF: breaking dense document into small pieces :) Starting from #28 👇👇👇

1

37

120

Abdulla A. Damluji, MD, PhD

@DrDamluji

9 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals Guidelines are detailed: reading them slowly Please, read full doc! Thread #16 : Renin-Angiotensin-Aldosterone Inhibitors & CCD? Let's try below:🥸📷👇

1

34

117

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 month

Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary InterventionA Systematic Review and Patient-Level Meta-Analysis: @JAMACardio 🥸 Good morning: more on SAPT monotherapy vs DAPT 😱Summary 👇👇👇

5

29

116

Abdulla A. Damluji, MD, PhD

@DrDamluji

11 months

Occupational Safety in the Cardiac Catheterization Laboratory: Time for Better Ergonomics: @JACCJournals 🥸Do you have back pain? Me too Read this summary 👇👇

7

39

113

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Unmet needs in valvular heart disease: @ESC_Journals Summary on gaps in knowledge for VHD 1/ 🏥 Optimize intervention timing & avoid late presentation to significantly impact population-level outcomes.

2

41

115

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia: @NEJM Great advancement in PAD MX and work led by @shishem and team Few highlights below 👇👇👇

1

24

113

Abdulla A. Damluji, MD, PhD

@DrDamluji

4 years

Nice lecture on wire characteristics... #CTO #CHIP #cardiotwitter

4

30

113

Abdulla A. Damluji, MD, PhD

@DrDamluji

10 months

Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations: @JACCJournals Here is weekend morning report to stay ahead of the published literature :) 🥸🥸🥸 Summary 👇👇👇

3

41

108

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

New clinical consensus from European Association of Percutaneous Cardiovascular Interventions & ESC Working Group on Cardiovascular Surgery on managing coronary artery disease in patients undergoing transcatheter aortic valve replacement: @ESC_Journals 10-Point Summary 👇👇👇

6

30

101

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 years

Before I forget: No one dies of a diagonal. Do not go crazy over that! Just saying!

23

7

99

Abdulla A. Damluji, MD, PhD

@DrDamluji

24 days

FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction: @NEJM 🥸 Trial #2 : FULL REVASC 😱 Summary 👇👇👇

1

32

100

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Outcomes after Critical Illness: @NEJM Cardiac critical care and CCM often overlap Here are few point summary 👇👇👇

4

34

99

Abdulla A. Damluji, MD, PhD

@DrDamluji

4 years

In 2002, I arrived to Johns Hopkins. During weekly transplant meetings that I had to attend, he was assertive/intimidating, but shielded me when I was “pimped” by liver attending. 18 yrs later, I read this. Here is a story of a good man #cardiotwitter

The Stunning Comeback of a Top Transplant Surgeon Who Got a New Heart at His Own Hospital

upworthyscience.com

5

26

98

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 years

10

17

98

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Bleeding Events After Transcatheter Aortic Valve Replacement: @JACCJournals (6-point summary on this nice review) 👇👇👇

6

25

97

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients: @NEJM @ACCinTouch #ACC23 #Trial Update 2 Editorializing: 15% of study population are older adults = @MichaelGNanna @Ajar_Kochar Clear Outcome Trial: 8 Point Summary Below 👇👇👇

4

22

96

Abdulla A. Damluji, MD, PhD

@DrDamluji

4 years

I was told interventional cardiologists cannot be clinician-scientisits or methodologists bec they have no time I learned that it largely depends on *Mentorship *Team *Environment Seek out to work with the best: you'll do great things @EllenJMacKenzie said I am a doctor :)

20

7

97

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

A Next-Generation Balloon-Expandable Transcatheter Aortic Valve First-in-Human Experience: @JACCJournals On #Duopoly : Now, let's wait for a balloon expandable valve from Medtronic! 10-point summary: Let's do it! 👇👇

1

30

96

Abdulla A. Damluji, MD, PhD

@DrDamluji

2 years

With the interventional cardiology celebrity ⁦ @adnanalkhouli ⁩

1

0

95

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 month

Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention-A Systematic Review and Network Meta-Analysis: @JAMA_current 🥸Led by @MichaelGNanna 😱Brief 10-point summary 👇👇👇

1

22

94

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 months

Reperfusion in Patients With ST-Segment–Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport Times: @CircIntv 🥸Great work by @seanvandiepen 😱Summary below 👇👇

3

28

95

Abdulla A. Damluji, MD, PhD

@DrDamluji

7 months

A Geriatric Approach to Percutaneous Coronary Interventions in Older Adults, Part II: @JACCJournals @MichaelGNanna 🥸: I meant to summarize this a while back, but here it is below: 🥸At the cross road of Geriatrics and Interventional Cardiology: Happy Sunday 👇👇👇

1

42

94

Abdulla A. Damluji, MD, PhD

@DrDamluji

25 days

🥸Five points from associated editorial by @SVRaoMD on DanGer Shock: @NEJM 👇👇

Abdulla A. Damluji, MD, PhD

@DrDamluji

25 days

Microaxial Flow Pump or Standard Care in Infarct Related Cardiogenic Shock: @NEJM 🥸It was quite busy in ACC to tweet, but will try to summarize few highlights for trials if anyone missed them. 😱Starting with DanGer Shock: funded by Abiomed Summary 👇👇👇

4

14

48

2

19

93

Abdulla A. Damluji, MD, PhD

@DrDamluji

23 days

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction: @NEJM 🥸 Trial #3 : REDUCE-AMI from Sweden, Estonia, and New Zealand. 😱 Long-term beta blockers among patients with AMI + EF>50% did not lead to lower MACE. 🥸 Summary 👇👇👇

3

22

91

Abdulla A. Damluji, MD, PhD

@DrDamluji

21 days

Chronological vs Biological Age inInterventional Cardiology - A Comprehensive Approach to Care for Older Adults: JACC Family Series @JACCJournals @adnanalkhouli 🥸We study "older" patients undergoing percutaneous procedures. Older is not only "number". 😱Summary 👇👇👇

4

20

91

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Angina After Percutaneous Coronary Intervention: Patient and Procedural Predictors: @CircIntv 1 in 3 patients post FFR guided PCI had symptoms, but delta FFR (pre vs post) may be useful predictor of post PCI angina! Here is 10 point summary 👇👇👇

1

24

90

Abdulla A. Damluji, MD, PhD

@DrDamluji

2 years

Here is a great case - 1/ Transfer from outside hospital Older adult >70 Angina, trop +

16

20

88

Abdulla A. Damluji, MD, PhD

@DrDamluji

6 months

Day 3 #AHA23 @AHA_Research 🥸Late breaking clinical trials 😱3 more trials in this short thread: 1. 🥸 SPEECH: In a trial of adults with heart failure, a speech analysis app predicted the need for hospitalization about three weeks in advance of a heart failure. 👇👇👇

3

26

89

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 month

Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial: @ESC_Journals 🥸Nitrate-CIN trial: in-organic nitrate reduced CIN and MACE in ACS pts 😱 Interesting work from Barts 🥸Summary 👇👇👇

1

25

85

Abdulla A. Damluji, MD, PhD

@DrDamluji

2 years

Great case to show value of #IVUS 1/8 NSTEMI

7

21

85

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Outcomes of Bioprosthetic Valve Fracture in Patients Undergoing Valve-in-Valve TAVR: @JACCJournals Many years of collecting these cases: amazing work @AdnanChatriwala 👏👏 Summary in 15 short bullets 👇👇👇

4

26

85

Abdulla A. Damluji, MD, PhD

@DrDamluji

4 years

Do you take care of patients with acute #cardiovascular #disease ? How many of these patients are #older #adults ? Do you treat these older patients differently? We address these complexities in an AHA Scientific Statement @CircAHA @DrMauricioCohen

7

41

84

Abdulla A. Damluji, MD, PhD

@DrDamluji

8 months

Wow wow wow @ACCinTouch @SCAI @HFSA

3

10

85

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Management of Guidewire Entrapment and Fracture During Percutaneous Coronary Intervention: When All Bailout Techniques Fail: @pfeffer_brad Here is a brief summary in management of wire entrapment AND/OR fracture 👇👇

4

25

84

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 months

Ischemic heart disease in patients with cancer: @ESC_Journals 🥸Nice comprehensive review. 😱30+ point highlights are below; please read full text 👇👇

2

40

82

Abdulla A. Damluji, MD, PhD

@DrDamluji

9 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals * I am reading this slowly and summarizing in threads: read full doc *** guidelines support team approach to chronic coronary disease 🥸 Thread #4 👇👇👇

1

20

82

Abdulla A. Damluji, MD, PhD

@DrDamluji

5 months

Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock: @JACCJournals 🥸 Few points on vascular access management in the cardiac intensive care unit 😱Full discussion here👇 😱Summary here 👇

2

32

80

Abdulla A. Damluji, MD, PhD

@DrDamluji

4 months

Cardiac Catheterization Laboratory Management of the Comatose Adult Patient With an Out-of-Hospital Cardiac Arrest: @CircAHA @AHAScience @AHA_Research 🥸 GM: Dense document - please read full report. 😱I will try to keep it <40 pts: Scroll below for highlights 👇👇👇

1

24

80

Abdulla A. Damluji, MD, PhD

@DrDamluji

2 months

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials: @CircAHA 🥸wow: more on left main+diabetes: PCI vs CABG! 😱 Summary 👇👇👇

1

20

79

Abdulla A. Damluji, MD, PhD

@DrDamluji

9 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals Guidelines are detailed: reading it slowly Please, read full doc! Thread #13 : Physical activity and environmental exposures in the context of CCD? 🥸👇👇

1

24

78

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Thread #2 : 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: @JACCJournals * Easier to digest in small snippets, but not sure how to do this best, but let's experiment. ...continued starting from 13 through 18

2

30

77

Abdulla A. Damluji, MD, PhD

@DrDamluji

7 months

Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC) -- This is a great effort by @ronwaksman SHARC Is out! 👇👇👇

1

20

78

Abdulla A. Damluji, MD, PhD

@DrDamluji

23 days

🥸5 summary points from associated editorial by @gabrielsteg 👇👇👇

Abdulla A. Damluji, MD, PhD

@DrDamluji

23 days

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction: @NEJM 🥸 Trial #3 : REDUCE-AMI from Sweden, Estonia, and New Zealand. 😱 Long-term beta blockers among patients with AMI + EF>50% did not lead to lower MACE. 🥸 Summary 👇👇👇

3

22

91

2

26

77

Abdulla A. Damluji, MD, PhD

@DrDamluji

10 months

Assessment and Management of Older Adults Undergoing PCI, Part 1: A @JACCJournals Expert Panel *From the @ACCinTouch interventional cardiology and geriatric cardiology leadership councils. **led by the great Dr @MichaelGNanna . Out today 👇👇

1

24

75

Abdulla A. Damluji, MD, PhD

@DrDamluji

3 years

Contraindications to using the arm for right heart catheterization are: * Obstruction to radial drainage * Breast surgery * Trauma *SVC syndromes Otherwise, median antecubital vein should be the default access site for RHC

9

18

74

Abdulla A. Damluji, MD, PhD

@DrDamluji

8 months

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals - Tips on SCAD from the guidelines Let's keep short 🥸🥸👇👇

1

9

74

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Critical Care Enrichment During Advanced Heart Failure Training: @JACCJournals By the great: @JasonKatzMD and team. - The title should have read advanced heart failure and interventional cardiology training! Highlights below. 👇👇👇

2

23

74

Abdulla A. Damluji, MD, PhD

@DrDamluji

1 year

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension: @NEJM More advancement in the pulmonary hypertension space! (Funded by Acceleron Pharma, a subsidiary of MSD) Summary below! 👇👇👇

2

12

71

Abdulla A. Damluji, MD, PhD

@DrDamluji

10 months

Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves: @JACCJournals The rate of PPI: Acurate neo: 8.8% Acurate neo2: 7.7% Evolut PRO: 15.2% Evolut PRO+: 10.4% Summary 👇👇

2

12

72